Perrigo Company PLC PRGO Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Andersen Svend

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

13,376

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Schmelter Triona

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

17,197

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Quinn Grainne

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,210

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Lockwood-Taylor Patrick

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

53,503

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Bezerra Eduardo Guarita

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

17,197

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Farrington Thomas

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,640

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Willis Robert

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,210

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Janish Ronald Craig

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

8,121

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Ives Alison

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

7,166

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Hanson Kyle

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

12,420

Price:

--

Filings by filing date

Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Andersen Svend

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

13,376

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Schmelter Triona

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

17,197

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Quinn Grainne

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,210

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Lockwood-Taylor Patrick

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

53,503

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Bezerra Eduardo Guarita

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

17,197

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Farrington Thomas

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,640

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Willis Robert

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,210

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Janish Ronald Craig

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

8,121

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Ives Alison

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

7,166

Price:

--
Apr 05, 2024 (filed on Apr 09, 2024)

Insider Name:

Hanson Kyle

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

12,420

Price:

--

News

Biz Brief

Sector: Healthcare	Industry: Pharmaceuticals

See Regulatory Filings on SEC

Company Contact

Address:	The Sharp Building Hogan Place, Dublin 2 DUBLIN D02 TY74
Tel:	1-269-6863373
Website:	https://www.perrigo.com
IR:	See website

Key People

Patrick Lockwood-Taylor President, Chief Executive Officer, Director	Catherine Schmelter Executive Vice President, President - Consumer Self-Care Americas and Global Portfolio Optimization	Eduardo Guarita Bezerra Chief Financial Officer, Executive Vice President
Robert Willis Chief Human Resource Officer, Executive Vice President	Thomas M. Farrington Executive Vice President, Chief Information Officer	Alison Ives Executive Vice President, Chief Scientific Officer
Kyle L. Hanson Executive Vice President, General Counsel, Company Secretary	Svend Andersen Executive Vice President, President - Consumer Self-Care International	Ronald Craig Janish Executive Vice President - Global Operations and Supply Chain, Chief Transformation Officer
Grainne Quinn Executive Vice President, Chief Medical Officer

Business Overview

Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.

Financial Overview

For the fiscal year ended 31 December 2023, Perrigo Company PLC revenues increased 5% to $4.66B. Net loss before extraordinary items decreased 97% to $4.4M. Revenues reflect CSCI segment increase of 11% to $1.69B, CSCA segment increase of 1% to $2.96B, Europe segment increase of 10% to $1.62B, United States segment increase of 2% to $2.92B, All other countries segment increase of 8% to $116.3M.

Employees:	9,140 as of Dec 31, 2023

Reporting Currency:	U.S. Dollars
Enterprise value:	$7,396M as of Dec 31, 2023
Annual revenue (TTM):	$4,656M as of Dec 31, 2023
EBITDA (TTM):	$643.40M as of Dec 31, 2023
Net annual income (TTM):	-$4.50M as of Dec 31, 2023
Free cash flow (TTM):	$154.10M as of Dec 31, 2023
Net Debt Last Fiscal Year:	$3,322M as of Dec 31, 2023
Shares outstanding:	135,515,939 as of Feb 23, 2024
Index Membership:	S&P 400 Mid Cap
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization